[1] [1] VANDEPUTTE M M，VAN UYTFANGHE K，LAYLE N K，et al.Synthesis，chemical characterization, and -opi-oid receptor activity assessment of the emerging group of“nitazene” 2-benzylbenzimidazole synthetic opioids[J]. ACS Chemical Neuroscience, 2021, 12（7）： 1241-1251.

[2] [2] GROSS F, TURRIAN H. ber Benzimidazolderivate mit starker analgetischer Wirkung[J]. Experientia, 1957, 13（10）： 401-403.

[3] [3] World Health Organization （WHO）. Critical review re-port： Metonitazene[EB/OL]. [2024-02-17]. https：//www.who.int/publications/m/item/metonitazene---critical-revie w-report.

[4] [4] BLANCKAERT P, CANNAERT A, VAN UYTFANGHE K,et al.Report on a novel emerging class of highly po-tent benzimidazole NPS opioids：Chemical andin vitrofunctional characterization of isotonitazene[J]. Drug Testing and Analysis，2020, 12（4）：422-430.

[5] [5] Schedules of controlled substances： Temporary place-ment of butonitazene, etodesnitazene, flunitazene, metodesnitazene, metonitazene, N-pyrrolidino etonitazene, and protonitazene in schedule I[J]. Federal Register, 2022, 87（70）：21556-21561.

[6] [6] MORIOKA F, FUJII S, KAMATA H,et al.Postmortem examination and toxicological analysis for acute metonitazene intoxication in Japan： A case report[J]. Legal Medicine, 2023, 61： 102216.

[7] [7] MONTANARI E, MADEO G, PICHINI S,et al.Acute in-toxications and fatalities associated with benzimidazole opioid （nitazene analog） use： A systematic review[J]. Therapeutic Drug Monitoring, 2022, 44（4）：494-510.

[8] [8] KROTULSKI A J, PAPSUN D M, WALTON S E,et al.Metonitazene in the United States—Forensic toxicology assessment of a potent new synthetic opioid using liquid chromatography mass spectrometry[J]. Drug Testing and Analysis, 2021, 13（10）： 1697-1711.

[9] [9] BLANCKAERT P, BALCAEN M, VANHEE C,et al.Analytical characterization of "etonitazepyne," a new pyrrolidinyl-containing 2-benzylbenzimidazole opioid sold online [J]. Drug Testing and Analysis, 2021, 13（9）：1627-1634.

[10] [10] PAPSUN D M, KROTULSKI A J, LOGAN B K. Proliferation of novel synthetic opioids in postmortem investigations after core-structure scheduling for fentanyl-related substances[J]. The American Journal of Forensic Medicine and Pathology，2022，43（4）：315-327.

[11] [11] PARDI J，FORD S，COOPER G. Validation of an analytical method for quantitation of metonitazene and isotonitazene in plasma, blood, urine, liver and brain and application to authentic postmortem casework in New York City[J]. Journal of Analytical Toxicology, 2023, 47（8）： 648-655.

[12] [12] SCHLLER M，LUCIC I，IESTAD M L，et al.High-throughput quantification of emerging “nitazene” benz-imidazole opioid analogs by microextraction and UHPLC-MS-MS[J]. Journal of Analytical Toxicology，2023，47（9）： 787-796.

[15] [15] KROTULSKI A J, WALTON S E, FOGARTY M F,et al.NPS discovery toolkit： Metonitazene[EB/OL]. [2024-02-17]. https：//www.cfsre.org/images/toolkits/Metonita-zene_NPS-Discovery-Toolkit_072021.pdf.